{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:18:44Z","timestamp":1777526324343,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00403-020-02078-x","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T05:02:33Z","timestamp":1588222953000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic efficacy and safety of oral tranexamic acid 250\u00a0mg once a day versus 500\u00a0mg twice a day: a comparative study"],"prefix":"10.1007","volume":"313","author":[{"given":"Bhumika","family":"Chowdhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram K.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karaninder S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpinder S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket","family":"Vashist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/0019-5154.80416","volume":"56","author":"A Achar","year":"2011","unstructured":"Achar A, Rathi SK (2011) Melasma: a clinico-epidemiological study of 312 cases. Indian J DermatoL 56:380\u2013382","journal-title":"Indian J DermatoL"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/14764172.2012.685478","volume":"14","author":"P Kanechorn Na Ayuthaya","year":"2012","unstructured":"Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A (2012) Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther 14:150\u2013154. https:\/\/doi.org\/10.3109\/14764172.2012.685478","journal-title":"J Cosmet Laser Ther"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0974-2077.118403","volume":"6","author":"L Budamakuntla","year":"2013","unstructured":"Budamakuntla L, Loganathan E, Suresh DH, Shanmugam S, Suryanarayan S, Dongare A et al (2013) Microinjections and microneedling in patients with melasma. J Cutan Aesthet Surg 6:139\u2013143","journal-title":"J Cutan Aesthet Surg"},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1468-3083.2009.03251.x","volume":"23","author":"T Cestari","year":"2009","unstructured":"Cestari T, Arellano I, Hexsel D, Ortonne JP (2009) Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venerol 23:760\u2013772","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"2078_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/09546634.2011.643220","volume":"24","author":"HH Cho","year":"2013","unstructured":"Cho HH, Choi M, Cho S, Lee JH (2013) Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. J Dermatol Treat 24:292\u2013296","journal-title":"J Dermatol Treat"},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/2349-5847.196295","volume":"3","author":"A George","year":"2016","unstructured":"George A (2016) Tranexamic acid: An emerging depigmenting agent. Pigment Int 3:66\u201371. https:\/\/doi.org\/10.4103\/2349-5847.196295","journal-title":"Pigment Int"},{"key":"2078_CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1468-3083.2010.03592.x","volume":"24","author":"C Guinot","year":"2010","unstructured":"Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K et al (2010) Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol 24:1060\u20131069","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3126\/kumj.v10i4.10993","volume":"10","author":"D Karn","year":"2012","unstructured":"Karn D, Kc S, Amatya A, Razouria EA, Timalsina M (2012) Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J 10:40\u201343 PMID: 23575051","journal-title":"Kathmandu Univ Med J"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/ijdvl.IJDVL_801_16","volume":"85","author":"VK Khurana","year":"2019","unstructured":"Khurana VK, Misri RR, Agarwal S, Thole AV, Kumar S, Anand T et al (2019) A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Indian J Dermatol Venereol Leprol 85:39\u201343","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2078_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","volume":"46","author":"EH Kim","year":"2007","unstructured":"Kim EH, Kim YC, Lee ES, Kang HY (2007) The vascular characteristics of melasma. J Dermatol Sci 46:111\u2013116","journal-title":"J Dermatol Sci"},{"key":"2078_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/ced.12835","volume":"41","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Park J-Y, Shibata T, Fujiwara R, Kang HY (2016) Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol 41:480\u2013485","journal-title":"Clin Exp Dermatol"},{"key":"2078_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","volume":"130","author":"CK Kimbrough-Green","year":"1994","unstructured":"Kimbrough-Green CK, Griffiths CEM, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN et al (1994) Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol 130:727\u2013733","journal-title":"Arch Dermatol"},{"key":"2078_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TG, Goh CL (2016) Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. J Am Acad Dermatol 75:385\u2013392","journal-title":"J Am Acad Dermatol"},{"key":"2078_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/jdv.12209","volume":"28","author":"Y Li","year":"2014","unstructured":"Li Y, Sun Q, He Z, Fu L, He C, Yan Y (2014) Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial. J Eur Acad Dermatol Venereol 28:393\u2013394. https:\/\/doi.org\/10.1111\/jdv.12209","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2078_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1011-1344(98)00212-7","volume":"47","author":"K Maeda","year":"1998","unstructured":"Maeda K, Naganuma M (1998) Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol 47:136\u2013141 PMID: 10093913","journal-title":"J Photochem Photobiol"},{"key":"2078_CR16","first-page":"437","volume":"44","author":"E Mafune","year":"2008","unstructured":"Mafune E, Morimoto Y, Iizuka Y (2008) Tranexamic acid and melisma. Farumashia 44:437\u201342","journal-title":"Farumashia"},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","volume":"27","author":"JI Na","year":"2013","unstructured":"Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC (2013) Effect of Tranexamic acid on melasma: A clinical trial with histological evaluation. J Eur Acad Dermatol Venereol 27:1035\u20131039","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2078_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/1346-8138.12573","volume":"41","author":"TK Noh","year":"2014","unstructured":"Noh TK, Choi SJ, Chung BY, Kang JS, Lee JH, Lee MW et al (2014) Inflammatory features of melasma lesions in Asian skin. J Dermatol 41:788\u2013794","journal-title":"J Dermatol"},{"key":"2078_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.det.2007.05.004","volume":"25","author":"JS Pasricha","year":"2007","unstructured":"Pasricha JS, Khaitan BK, Dash S (2007) Pigmentary disorders in India. Dermatol Clin 25:343\u2013352","journal-title":"Dermatol Clin"},{"key":"2078_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/09546630601028778","volume":"18","author":"MD Pawaskar","year":"2007","unstructured":"Pawaskar MD, Parikh P, Markowski T, Mc Michael AJ, Feldman SR, Balkrishan R (2007) Melasma and its impact on health related QOL in Hispanic women. J Dermatolog Treat 18:5\u20139","journal-title":"J Dermatolog Treat"},{"key":"2078_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-4632.2009.03778.x","volume":"48","author":"R Picardo","year":"2009","unstructured":"Picardo R, Vallejos Q, Feldman SR, Schultz MR, Verma A, Quandt SA et al (2009) The prevalence of melasma and its association with quality of life among male migrant Latino workers. Int J Dermatol 48:22\u201326","journal-title":"Int J Dermatol"},{"key":"2078_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/2349-5847.219672","volume":"4","author":"I Podder","year":"2017","unstructured":"Podder I, Sarkar R (2017) Systemic therapy for melasma: Exploring newer options \u2013 A comprehensive review. Pigment Int 4:78\u201384. https:\/\/doi.org\/10.4103\/2349-5847.219672","journal-title":"Pigment Int"},{"key":"2078_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/316219","author":"N Prabha","year":"2014","unstructured":"Prabha N, Mahajan VK, Mehta KS, Chauhan PS, Gupta M (2014) Cosmetic contact sensitivity in patients with Melasma: Results of a pilot study. Dermatol Res Practice. https:\/\/doi.org\/10.1155\/2014\/316219","journal-title":"Dermatol Res Practice"},{"key":"2078_CR24","first-page":"018","volume":"1","author":"N Puri","year":"2015","unstructured":"Puri N (2015) Oral tranexamic acid versus triple combination for the treatment of melasma. J J Expt Derm Res 1:018","journal-title":"J J Expt Derm Res"},{"key":"2078_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1468-3083.2009.03524.x","volume":"24","author":"R Sarkar","year":"2010","unstructured":"Sarkar R, Puri P, Jain RK, Singh A, Desai A (2010) Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol 24:68\u201372. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03524.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2078_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4103\/idoj.IDOJ_187_17","volume":"8","author":"N Sarma","year":"2017","unstructured":"Sarma N, Chakraborty S, Poojary SA, Rathi S, Kumaran S, Nirmal B et al (2017) Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma. Indian Dermatol Online J 8:406\u2013442","journal-title":"Indian Dermatol Online J"},{"key":"2078_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/ced.13164","volume":"42","author":"R Sharma","year":"2017","unstructured":"Sharma R, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Shiny TN (2017) Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol 42:728\u2013734","journal-title":"Clin Exp Dermatol"},{"issue":"3 Pt 1","key":"2078_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/dsu.12060","volume":"39","author":"JU Shin","year":"2013","unstructured":"Shin JU, Park J, Oh H, Lee JH (2013) Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnetlaser treatmentfor melasma in Koreans: a randomized, prospective trial. Dermatol Surg 39(3 Pt 1):435\u2013442","journal-title":"Dermatol Surg"},{"key":"2078_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12465","author":"M Taraz","year":"2017","unstructured":"Taraz M, Niknam S, Ehsani AH (2017) Tranexamic acid in the treatment of melasma: A comprehensive review of clinical studies. Dermatol Therapy. https:\/\/doi.org\/10.1111\/dth.12465","journal-title":"Dermatol Therapy"},{"key":"2078_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jocd.12026","volume":"12","author":"TW Tse","year":"2013","unstructured":"Tse TW, Hui E (2013) Tranexamic acid: An important adjuvant in the treatment of melasma. J Cosmet Dermatol 12:57\u201366","journal-title":"J Cosmet Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02078-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T23:29:57Z","timestamp":1722814197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02078-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02078-x","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no competing interest and therefore nothing else to declare, and have contributed significantly and take full responsibility for the manuscript. The authors of the paper are obliged to confirm that it has not been previously published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Institutional Ethics Committee (Rgn no ECR\/490\/Inst\/HP\/2013\/RR-16) and registered with Clinical Trial Registry of India (CTRI No. REF\/2018\/03\/018038).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from study subjects for enrollment and publication of material with the understanding that their names and initials will not be published and due efforts will be made to conceal their identity but anonymity cannot be guaranteed. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki declaration of 1975 as revised in 1983","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}